Stocks · Health care · Pharmaceutical Preparations

BICYCLE THERAPEUTICS PLC

BCYC Clue Score56

United Kingdom Fiscal year ends December CIK 0001761612 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net buying

By person

34 insiders · 272 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Baker Bros. Advisors LP entity

Director

$21.23M (10)

—

+$21.23M

10,018,674

14.35%

$35.77M

+64.8%

Pierre Legault

Director

—

$10.04M (10) scheduled

−$10.04M

46,000

0.0659%

$164.22K

—

Kevin Lee

Chief Executive Officer

—

$9.64M (73) scheduled

−$9.64M

595,866

0.8535%

$2.13M

+116.6%

Carolyn Ng

Director

$8.00M (1)

—

+$8.00M

2,192,597

3.14%

$7.83M

—

Svlsf V, LLC entity

10% owner

$5.40M (2)

—

+$5.40M

1,915,274

2.74%

$6.84M

—

Deborah Harland

Director

$5.40M (1)

—

+$5.40M

1,915,275

2.74%

$6.84M

—

GSK plc entity

10% owner

$5.40M (1)

$91.83K (3)

+$5.31M

1,910,531

2.74%

$6.82M

—

Tybourne Capital Management (Hk) Ltd entity

10% owner

$5.10M (1)

—

+$5.10M

1,957,961

2.80%

$6.99M

—

Michael Anstey

Director

$4.40M (1)

—

+$4.40M

1,751,437

2.51%

$6.25M

—

Cambridge Innovation Capital (Jersey) Ltd entity

10% owner

$4.40M (1)

—

+$4.40M

1,751,437

2.51%

$6.25M

—

Kate Bingham

Director

$5.40M (2)

$1.53M (4)

+$3.87M

1,910,016

2.74%

$6.82M

+4,719%

Nigel Crockett

Chief Business Officer

—

$2.83M (14) scheduled

−$2.83M

51,053

0.0731%

$182.26K

—

Lee Kalowski

President and CFO

—

$2.82M (16) scheduled

−$2.82M

30,309

0.0434%

$108.20K

—

Novartis Bioventures Ltd entity

10% owner

$2.36M (1)

—

+$2.36M

1,769,641

2.53%

$6.32M

—

Nicholas Keen

Chief Scientific Officer

—

$1.86M (17)

−$1.86M

62,024

0.0888%

$221.43K

+50.1%

Michael Skynner

Chief Scientific Officer

—

$366.60K (24)

−$366.60K

154,726

0.2216%

$552.37K

+276.3%

Alistair Milnes

Chief Operating Officer

—

$364.03K (18)

−$364.03K

136,717

0.1958%

$488.08K

+5,780%

Travis Alvin Thompson

Chief Financial Officer

—

$282.86K (29) scheduled

−$282.86K

64,449

0.0923%

$230.08K

+610.3%

Michael Charles Ferguson Hannay

Chief Prod & Supply Chain Off

—

$120.20K (19)

−$120.20K

92,561

0.1326%

$330.44K

+299.9%

Alethia Young

Chief Financial Officer

—

$77.42K (8) scheduled

−$77.42K

87,081

0.1247%

$310.88K

—

Santiago Arroyo

Chief Development Officer

—

$69.65K (1)

−$69.65K

69,057

0.0989%

$246.53K

—

Dominic Smethurst

Chief Medical Officer

—

$52.34K (1)

−$52.34K

36,699

0.0526%

$131.02K

—

Jennifer Scott Perry

Chief Operating Officer

—

$18.33K (9) scheduled

−$18.33K

89,552

0.1283%

$319.70K

−4.6%

Robert Charles Swanton

Director

—

$12.78K (2)

−$12.78K

15,782

0.0226%

$56.34K

+410.9%

Vertex Global Healthcare Fund I Pte Ltd. entity

10% owner

—

—

—

1,621,168

2.32%

$5.79M

—

Gregory Paul Winter

Director

—

—

—

196,427

0.2814%

$701.24K

+296.0%

Jose-Carlos Gutierrez-Ramos

Director

—

—

—

32,500

0.0466%

$116.03K

—

Janice Bourque

Director

—

—

—

32,500

0.0466%

$116.03K

—

Stephen H. Sands

Director

—

—

—

26,893

0.0385%

$96.01K

—

Richard N Kender

Director

—

—

—

23,000

0.0329%

$82.11K

—

Alessandro Riva

Director

—

—

—

19,880

0.0285%

$70.97K

—

Veronica GH Jordan

Director

—

—

—

16,750

0.0240%

$59.80K

—

Herve Hoppenot

Director

—

—

—

15,532

0.0222%

$55.45K

—

Roger D Dansey

Director

—

—

—

15,532

0.0222%

$55.45K

—